Skip to content
healthcare.dev

Lamotrigine

NDC 82009-132, Lamotrigine, tablet, from Quallent Pharmaceuticals Health LLC.

Product NDC
82009-132
Status
Listed
Labeler
Quallent Pharmaceuticals Health LLC
Dosage form
TABLET
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA077633
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/82009-132 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • LAMOTRIGINE100 mg/1

Pharmacologic classes

Anti-epileptic Agent [EPC]; Decreased Central Nervous System Disorganized Electrical Activity [PE]; Dihydrofolate Reductase Inhibitors [MoA]; Mood Stabilizer [EPC]; Organic Cation Transporter 2 Inhibitors [MoA]

Package NDCNDC-11Package
82009-132-10820090132101000 TABLET in 1 BOTTLE (82009-132-10)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/7977c87f-b459-486a-9edc-0a2071c46f4c
  • NADAC price for package 82009013210

    GET /v1/drugs/nadac/82009013210

Use it

Look up 82009-132 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/82009-132 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 82009-132. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.